MyFinsight
Home
About
Contact
Back
Income Statement
Allogene Therapeutics, Inc. (ALLO)
source: myfinsight.com
Download
Download image
Net comprehensive
loss
-$51,031K
(22.93%↑ Y/Y)
Interest and other
income, net
$6,187K
Net loss
-$50,943K
(23.23%↑ Y/Y)
Net unrealized gain
(loss) on...
-$88K
(-159.86%↓ Y/Y)
Total other income
(expense), net
$5,876K
(15.83%↑ Y/Y)
Interest expense
$268K
Other income
(expenses), net
-$43K
(-150.59%↓ Y/Y)
Loss from operations
-$56,819K
(20.46%↑ Y/Y)
Total operating
expenses
$56,819K
(-20.46%↓ Y/Y)
General and
administrative
$14,281K
(-11.23%↓ Y/Y)
Impairment of long-lived
assets
$2,382K
(-52.25%↓ Y/Y)
Research and development
$40,156K
(-20.25%↓ Y/Y)
Back